Glyburide is anti-inflammatory and associated with reduced mortality in melioidosis.
BACKGROUND: Patients with diabetes mellitus are more prone to bacterial sepsis, but there are conflicting data on whether outcomes are worse in diabetics after presentation with sepsis. Glyburide is an oral hypoglycemic agent used to treat diabetes mellitus. This K(ATP)-channel blocker and broad-spe...
主要な著者: | Koh, G, Maude, R, Schreiber, M, Limmathurotsakul, D, Wiersinga, W, Wuthiekanun, V, Lee, S, Mahavanakul, W, Chaowagul, W, Chierakul, W, White, N, van der Poll, T, Day, N, Dougan, G, Peacock, S |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2011
|
類似資料
-
Risk factors for recurrent melioidosis in northeast Thailand.
著者:: Limmathurotsakul, D, 等
出版事項: (2006) -
Glyburide reduces bacterial dissemination in a mouse model of melioidosis.
著者:: Gavin C K W Koh, 等
出版事項: (2013-01-01) -
Role and significance of quantitative urine cultures in diagnosis of melioidosis.
著者:: Limmathurotsakul, D, 等
出版事項: (2005) -
Diabetes does not influence activation of coagulation, fibrinolysis or anticoagulant pathways in Gram-negative sepsis (melioidosis).
著者:: Koh, G, 等
出版事項: (2011) -
Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei.
著者:: Wiersinga, W, 等
出版事項: (2006)